Cargando…

Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration

Adverse effects of drug combinations and their underlying mechanisms are highly relevant for safety evaluation, but often not fully studied. Hydroxychloroquine (HCQ) and azithromycin (AZM) were used as a combination therapy in the treatment of COVID-19 patients at the beginning of the pandemic, lead...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wener, Luo, Xiaojing, Poetsch, Mareike S., Oertel, Reinhard, Nichani, Kapil, Schneider, Martin, Strano, Anna, Hasse, Marcel, Steiner, Robert-Patrick, Cyganek, Lukas, Hettwer, Karina, Uhlig, Steffen, Simon, Kirsten, Guan, Kaomei, Schubert, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877825/ https://www.ncbi.nlm.nih.gov/pubmed/35215332 http://dx.doi.org/10.3390/ph15020220

Ejemplares similares

IP3R-Mediated Compensatory Mechanism for Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Cardiac Ryanodine Receptor Deficiency
por: Luo, Xiaojing, et al.
Publicado: (2020)

Role of Leptin in Cardiovascular Diseases
por: Poetsch, Mareike S., et al.
Publicado: (2020)

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine
por: Poetsch, Mareike S, et al.
Publicado: (2022)

Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation
por: Li, Wener, et al.
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
por: Andreani, Julien, et al.
Publicado: (2020)

Development of Non-Targeted Mass Spectrometry Method for Distinguishing Spelt and Wheat
por: Nichani, Kapil, et al.
Publicado: (2022)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Anticoagulants/azithromycin/hydroxychloroquine: Spontaneous haematoma: case report
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: SDRIFE-like rash: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Various toxicities: 4 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy
por: Scherrmann, JM.
Publicado: (2020)

Induced pluripotent stem cells of patients with Tetralogy of Fallot reveal transcriptional alterations in cardiomyocyte differentiation
por: Grunert, Marcel, et al.
Publicado: (2020)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Amphotericin-b-liposomal/azithromycin/hydroxychloroquine: No response: case report
Publicado: (2021)

Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
por: Xu, Jiuyang, et al.
Publicado: (2022)

Azithromycin/hydroxychloroquine/oseltamivir: Erythema multiforme major: case report
Publicado: (2021)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Azithromycin/favipiravir/hydroxychloroquine: Various toxicities: 7 case reports
Publicado: (2022)

Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
por: Wu, Qin, et al.
Publicado: (2023)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Azithromycin/hydroxychloroquine: Long QTc syndrome and hypoglycaemia: 3 case reports
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qvum3es9d1i4kdk9uouom4tbe